Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-01-07

Clinical Trial Update: Lithium Augmentation for Hyperarousal Symptoms of Post Traumatic Stress Disorder: Pilot Study [Phase 1]

View source ↗

Summary

A Phase 1 pilot study evaluating lithium augmentation for hyperarousal symptoms in post-traumatic stress disorder, with co-occurring mild traumatic brain injury…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lithium carbonate (Lithium carbonate)

Snippet

Sponsor: VA Eastern Colorado Health Care System | Conditions: Combat Posttraumatic Stess Disorder, Mild Traumatic Brain Injury | Phase 1 | Status: WITHDRAWN